GAMMA-TERPINENE
Relevant Data
Food Additives Approved by WHO:
Flavouring Substances Approved by European Union:
General Information
Mainterm | GAMMA-TERPINENE |
Doc Type | ASP |
CAS Reg.No.(or other ID) | 99-85-4 |
Regnum |
172.515 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 7461 |
IUPAC Name | 1-methyl-4-propan-2-ylcyclohexa-1,4-diene |
InChI | InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,7-8H,5-6H2,1-3H3 |
InChI Key | YKFLAYDHMOASIY-UHFFFAOYSA-N |
Canonical SMILES | CC1=CCC(=CC1)C(C)C |
Molecular Formula | C10H16 |
Wikipedia | γ-terpinene |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 136.238 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 0 |
Rotatable Bond Count | 1 |
Complexity | 171.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w A A A A A A A A A A A A A A A A A A A A A A A A A A A g A A A A A A A A A A A A A A A A G A A A A A A A D Q C A A A A C A A A A A A C A A i B C A A A A A A A g A A A A C A A A A A g A A A I A A Q A A A A A A g A A I A A I A A A A M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 0.0 |
Monoisotopic Mass | 136.125 |
Exact Mass | 136.125 |
XLogP3 | None |
XLogP3-AA | 2.8 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 10 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9431 |
Human Intestinal Absorption | HIA+ | 0.9972 |
Caco-2 Permeability | Caco2+ | 0.7302 |
P-glycoprotein Substrate | Non-substrate | 0.5833 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7997 |
Non-inhibitor | 0.9207 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8573 |
Distribution | ||
Subcellular localization | Lysosome | 0.5344 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8432 |
CYP450 2D6 Substrate | Non-substrate | 0.8145 |
CYP450 3A4 Substrate | Non-substrate | 0.5633 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7565 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8750 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9106 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8893 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8629 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6905 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9359 |
Non-inhibitor | 0.8680 | |
AMES Toxicity | Non AMES toxic | 0.9587 |
Carcinogens | Non-carcinogens | 0.5240 |
Fish Toxicity | High FHMT | 0.9627 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9811 |
Honey Bee Toxicity | High HBT | 0.8455 |
Biodegradation | Ready biodegradable | 0.5670 |
Acute Oral Toxicity | III | 0.8413 |
Carcinogenicity (Three-class) | Warning | 0.5576 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.7596 | LogS |
Caco-2 Permeability | 1.8334 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.5408 | LD50, mol/kg |
Fish Toxicity | 0.0908 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.8775 | pIGC50, ug/L |
From admetSAR
Toxicity Profile
Route of Exposure | |
---|---|
Mechanism of Toxicity | |
Metabolism | |
Toxicity Values | |
Lethal Dose | |
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
Minimum Risk Level | |
Health Effects | |
Treatment | |
Reference |
|
From T3DB
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Hydrocarbons |
Class | Unsaturated hydrocarbons |
Subclass | Branched unsaturated hydrocarbons |
Intermediate Tree Nodes | Not available |
Direct Parent | Branched unsaturated hydrocarbons |
Alternative Parents | |
Molecular Framework | Aliphatic homomonocyclic compounds |
Substituents | Branched unsaturated hydrocarbon - Cyclic olefin - Unsaturated aliphatic hydrocarbon - Olefin - Aliphatic homomonocyclic compound |
Description | This compound belongs to the class of organic compounds known as branched unsaturated hydrocarbons. These are hydrocarbons that contains one or more unsaturated carbon atoms, and an aliphatic branch. |
From ClassyFire
Targets
- General Function:
- Zinc ion binding
- Specific Function:
- Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.
- Gene Name:
- ESR1
- Uniprot ID:
- P03372
- Molecular Weight:
- 66215.45 Da
References
- Sipes NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ, Kavlock RJ, Knudsen TB: Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013 Jun 17;26(6):878-95. doi: 10.1021/tx400021f. Epub 2013 May 16. [23611293 ]
From T3DB